85 related articles for article (PubMed ID: 22261332)
1. Chmp1A acts as a tumor suppressor gene that inhibits proliferation of renal cell carcinoma.
You Z; Xin Y; Liu Y; Sun J; Zhou G; Gao H; Xu P; Chen Y; Chen G; Zhang L; Gu L; Chen Z; Han B; Xuan Y
Cancer Lett; 2012 Jun; 319(2):190-196. PubMed ID: 22261332
[TBL] [Abstract][Full Text] [Related]
2. Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells.
Li J; Belogortseva N; Porter D; Park M
Cell Cycle; 2008 Sep; 7(18):2886-93. PubMed ID: 18787405
[TBL] [Abstract][Full Text] [Related]
3. Chromatin modifying protein 1A (Chmp1A) of the endosomal sorting complex required for transport (ESCRT)-III family activates ataxia telangiectasia mutated (ATM) for PanC-1 cell growth inhibition.
Manohar S; Harlow M; Nguyen H; Li J; Hankins GR; Park M
Cell Cycle; 2011 Aug; 10(15):2529-39. PubMed ID: 21705858
[TBL] [Abstract][Full Text] [Related]
4. CHMP1A suppresses the growth of renal cell carcinoma cells via regulation of the PI3K/mTOR/p53 signaling pathway.
Wu Y; Wu Y; Xu C; Sun W; You Z; Wang Y; Zhang S
Genes Genomics; 2022 Jul; 44(7):823-832. PubMed ID: 35583792
[TBL] [Abstract][Full Text] [Related]
5. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway.
Park M; Upton D; Blackmon M; Dixon V; Craver S; Neal D; Perkins D
BMC Complement Altern Med; 2018 Feb; 18(1):71. PubMed ID: 29463243
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells.
Zheng J; Qin W; Jiao D; Ren J; Wei M; Shi S; Xi W; Wang H; Yang AG; Huan Y; Wen W
Int J Cancer; 2016 Oct; 139(7):1574-85. PubMed ID: 27193872
[TBL] [Abstract][Full Text] [Related]
7. Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells.
Li J; Orr B; White K; Belogortseva N; Niles R; Boskovic G; Nguyen H; Dykes A; Park M
Mol Cancer; 2009 Feb; 8():7. PubMed ID: 19216755
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
9. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
10. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
11. siRNA against TSG101 reduces proliferation and induces G0/G1 arrest in renal cell carcinoma - involvement of c-myc, cyclin E1, and CDK2.
Xu C; Zheng J
Cell Mol Biol Lett; 2019; 24():7. PubMed ID: 30675171
[TBL] [Abstract][Full Text] [Related]
12. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma.
Liu Z; Yan HY; Xia SY; Zhang C; Xiu YC
Mol Med Rep; 2016 Apr; 13(4):3206-12. PubMed ID: 26934858
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of β-arrestin2 induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cao YJ; Zhou YJ; He XZ; Zhou CX; Cui L; Zhuang QF; Xu RF
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1729-1737. PubMed ID: 28485809
[TBL] [Abstract][Full Text] [Related]
16. CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development.
Mochida GH; Ganesh VS; de Michelena MI; Dias H; Atabay KD; Kathrein KL; Huang HT; Hill RS; Felie JM; Rakiec D; Gleason D; Hill AD; Malik AN; Barry BJ; Partlow JN; Tan WH; Glader LJ; Barkovich AJ; Dobyns WB; Zon LI; Walsh CA
Nat Genet; 2012 Nov; 44(11):1260-4. PubMed ID: 23023333
[TBL] [Abstract][Full Text] [Related]
17. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
19. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated knockdown of vascular endothelial growth factor inhibits vascularization and tumor growth in renal cell carcinoma.
Gu M; Zhang K; Yao HJ; Zhou J; Peng YB; Xu MX; Wang Z
Int J Mol Med; 2015 Oct; 36(4):1063-72. PubMed ID: 26310563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
